药康生物：关于使用自有资金支付部分募投项目所需资金并以募集资金等额置换的公告

Core Viewpoint - The company announced the approval of a proposal to use its own funds to pay for part of the investment project costs, which will later be replaced with raised funds, ensuring the normal progress of the investment projects [1]. Group 1 - The company held its 13th meeting of the second board and the 12th meeting of the second supervisory board on August 21, 2025 [1]. - The proposal allows the company to use its own funds for part of the investment project costs during the implementation period, with a plan to replace these funds with raised funds later [1]. - The supervisory board expressed clear agreement on this matter, and the sponsor institution provided verification opinions, indicating that this matter does not require submission to the shareholders' meeting for approval [1].